[´Ý±â X]

Çùȸ¼Ò½Ä Çмú/ÇÐȸ º¸°ÇÁ¤Ã¥ Á¦¾à/À¯Åë ´Üü/º´¿ø ÀÇ·á±â±â ±â´É¼º½ÄÇ° ÇؿܼҽÄ
 
ȸ¿ø°¡ÀÔ ID/PWã±â
±â»ç°Ë»ö
2024-10-23,07:31(am)





¼ºÀκ´ ¿øÀΰú ¿¹¹æ
¼ºÀκ´ ¿îµ¿¿ä¹ý
¼ºÀκ´°ú ½Ä»ýÈ°
¼ºÀκ´ Çѹæ¿ä¹ý
µ¥½ºÅ© Ä®·³
´ç´¢º´ Ŭ¸®´Ð
°íÇ÷¾Ð Ŭ¸®´Ð µî
¼ºÀκ´ ¹¯°í´äÇϱâ
¹Ú´Þȸ ¼öÇÊ ¸±·¹ÀÌ
À¯ÇüÁر³¼ö Æ÷·³
±èö¼ö¿øÀå Æ÷·³
¾È¿õ½Ä±³¼ö Æ÷·³

 

[¼ö»ó]Á¦94Â÷ ´ëÇÑ»êºÎÀΰúÇÐȸ ÃÖ¿ì¼ö³í¹®»ó ¹ÚÁß½Åèâ
¼ºÀκ´´º½º (cdpnews@cdpnews.co.kr) 2008-09-30 ¿ÀÀü 9:24:00
¡¼ÃÖ¿ì¼ö³í¹®»ó¡½¸ðüžÆÀÇÇÐ(Accuvix»ó)-¹ÚÁß½Å(¼­¿ïÀÇ´ë): Measurement of Placental Alpha-Microglobulin-1 in Cervicovaginal Discharge to Diagnose Rupture of Membranes¦­»ý½Ä³»ºÐºñÇÐ(Astra Zeneca »ó)-±è¼ºÈÆ(¿ï»êÀÇ´ë) : Association between susceptibility to advanced stage endometriosis and the genetic polymorphisms of aryl hydrocarbon receptor repressor and glutathione-S-transferase T1 genes¦­ºÎÀÎÁ¾¾çÇÐ(Çѱ¹¿©¼º¾Ï¿¬±¸Àç´Ü»ó)-±èº´±â(¼º±Õ°üÀÇ´ë) : Phase ¥Ðstudy consolidation chemotherapy after concurrent chemoradiation in cervical cancer : Preliminary results¦­ÀϹݺÎÀΰúÇÐ(Bayer Schering pharma, Gynecare »ó)-À¯ÀºÈñ(°æÈñÀÇ´ë) : Predictors of leiomyoma recurrence after laparoscopic myomectomy ¡¼Çмú»ó¡½¼Û½ÂÀº(¼º±Õ°üÀÇ´ë) : Clinic outcomes of first trimester discordant twins ¦­ÁÖ´ÙÇý(¿ï»êÀÇ´ë) : The efficacy abd toxicity of docetaxel in patients with recurrent or persistent epithelial ovarian cancer
¡â ´ÙÀ½±Û : ¼º¸ðº´¿ø ¹®Á¤ÀÏ Áø·áºÎ¿øÀå, ¸¶¸£ÄûÁî ÈÄÁîÈÄ µîÀç
¡ä ÀÌÀü±Û : ÀÌ´ë¸ñµ¿º´¿ø ÁÖ¿õ ±³¼ö ÃÖ¿ì¼ö±¸¿¬»ó


 



¼­¿ï½Ã µ¿ÀÛ±¸ µ¿ÀÛµ¿ 102 - 31 ¹øÁö ȯ3ºôµù 402È£ / ÀüÈ­: 02-594-5906~8 / FAX: 02-594-5901
Copyrights (c) 2004 cdpnews.co.kr All rights reserved